Elsevier

Food and Chemical Toxicology

Volume 57, July 2013, Pages 179-184
Food and Chemical Toxicology

Amelioration of cyclophosphamide-induced hepatotoxicity by the root extract of Decalepis hamiltonii in mice

https://doi.org/10.1016/j.fct.2013.03.028Get rights and content

Highlights

  • The hepatoprotective potential of DHA against CP-induced liver damage.

  • DHA prevented the elevation of serum marker enzymes in CP-treated mice.

  • DHA enhanced the antioxidant defenses in the liver in vivo.

  • DHA inhibited down-regulation of antioxidant enzymes gene expressions.

Abstract

Hepatoprotective potential of the aqueous extract of the roots of Decalepis hamiltonii (DHA) against cyclophosphamide (CP)-induced oxidative stress has been investigated in mice. Administration of CP (25 mg/kg b.w., i.p) for 10 days induced hepatic damage as indicated by the serum marker enzymes aspartate and alanine transaminases (AST, ALT), alkaline phosphatase (ALP) and lactate dehydrogenase (LDH). Parallel to these changes CP induced oxidative stress in the liver as evident from the increased lipid peroxidation (LPO), reactive oxygen species (ROS), depletion of glutathione (GSH), and reduced activities of the antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), and glutathione-S-transferase (GST). Treatment with DHA (50 and 100 mg/kg b.w., po) mitigated the CP-induced oxidative stress. Moreover, expression of genes for the antioxidant enzymes, were down-regulated by CP treatment which was reversed by DHA. Our study shows the DHA protected the liver from toxicity induced by CP and therefore, it could be serve as a safe medicinal supplement during cyclophosphamide chemotherapy.

Introduction

Therapeutic effectiveness of anticancer drugs is associated with severe side effects due to their toxicity. Cyclophosphamide (CP) is one of the widely used anticancer drugs for its therapeutic efficacy against a variety of cancers and disorders like systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis (Goldberg et al., 1986, Dollery, 1999, Perini et al., 2007). Earlier studies have shown that therapeutic dose of CP could cause liver toxicity (Shulman et al., 1980, Bacon and Rosenberg, 1982, Snover et al., 1989). CP undergoes a metabolic activation by hepatic microsomal cytochrome P450 mixed functional oxidase system to produce the two metabolites, phosphoramide mustard and acrolein, which are responsible for induction of oxidative stress (Sladek, 1971, Ludeman, 1999). Experimental evidence suggests that oxidative stress is responsible for cyclophosphamide hepatotoxicity (Stankiewicz et al., 2002, Manda and Bhatia, 2003, Selvakumar et al., 2005). In order to overcome the toxic side effect of anti-cancer drugs, some antioxidant agents are considered useful to alleviate oxidative stress. Accordingly a combination of treatment regimen with potent and safe antioxidants could be the desirable approach to mitigate CP-induced toxicity (Bhatia et al., 2008, Jalali et al., 2012). A number of studies have shown that plant extracts with antioxidant activity protect against CP hepatotoxicity (Sharma et al., 2000, Haque et al., 2001, Haque et al., 2003, Kumar and Kuttan, 2005, Sudharsan et al., 2005).

Decalepis hamiltonii (Wight and Arn.) (family: Asclepiadaceae), a climbing shrub, grows in the forests of peninsular India. Its tuberous roots are consumed as pickles and juice for its health promoting properties in southern India. The roots are also used in folk medicine and ayurvedic (the ancient Indian traditional system of medicine) preparations as a general vitaliser (Nayar et al., 1978). Our earlier work has shown that the roots of D. hamiltonii possess potent antioxidant properties (Harish et al., 2005). In our laboratory several novel antioxidant compounds have been isolated and characterized, which could be associated with their alleged health benefits (Srivastava et al., 2006a, Srivastava et al., 2006b, Srivastava et al., 2007). The root extract of D. hamiltonii also show hepatoprotective and neuroprotective potential in the laboratory rat (Srivastava and Shivanandappa, 2006, Srivastava and Shivanandappa, 2009, Srivastava and Shivanandappa, 2010a, Srivastava and Shivanandappa, 2010b). Therefore, D. hamiltonii aqueous extract (DHA) could be a good source of antioxidants from edible sources. In this study, we have investigated the ameliorative potential of DHA against CP-induced liver toxicity in the laboratory mouse.

Section snippets

Chemicals

Cyclophosphamide (Ledoxan) was obtained from Dabur Pharma Limited, New Delhi, India. Nicotinamide adenine dinucleotide phosphate reduced (NADPH), 1-chloro-2,4-dinitrobenzene (CDNB), 2′,7′-dichlorofluorescin diacetate (DCF-DA), thiobarbituric acid (TBA), glutathione (GSH), oxidized glutathione (GSSG), glutathione reductase (GR), cumene hydroperoxide (CHP), pryogallol, bovine serum albumin (BSA), tetraethoxypropane, trichloroacetic acid (TCA), hydrogen peroxide (H2O2), 5,5′-dithiobis

Serum enzymes

Levels of the serum marker enzymes of hepatic damage, AST, ALT, LDH, and ALP were elevated in the CP treated mice whereas, in the DHA treated groups, they were comparable to the control group (Fig. 1).

Lipid peroxidation

CP increased the hepatic TBARS concentration significantly which was inhibited by DHA treatment. The higher dose of DHA (100 mg/kg b.w.) was most effective in inhibiting the hepatic lipid peroxidation (Fig. 2).

ROS

Induction of reactive oxygen species (ROS) was seen in the liver of CP treated mice which

Discussion

The side effects of cancer drug toxicity produce significant morbidity. Cyclophosphamide is metabolized by the microsomal enzymes in the liver to produce the two metabolites, phosphoramide mustard and acrolein (Ludeman, 1999). While phosphoramide mustard kills cancer cells by apoptosis, the acrolein causes toxic side effects on normal cells by inducing both apoptosis and necrotic cell death (Kern and Kehrer, 2002). There is evidence to indicate that antioxidants could protect normal cells

Conflict of Interest

The authors declare that there are no conflicts of interest.

Acknowledgments

The first author wishes to thank Prof. Cletus J.M. D’Souza, the Head of the Department of Biochemistry, University of Mysore, for his support and guidance at the time of this study.

References (56)

  • H. Ohkawa et al.

    Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

    Anal. Biochem.

    (1979)
  • A. Okado-Matsumoto et al.

    Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu, Zn-SOD in mitochondria

    J. Biol. Chem.

    (2001)
  • N.S. Rajasekaran et al.

    The effect of glutathione monoester (GME) on glutathione (GSH) depleted rat liver

    J. Nutr. Biochem.

    (2002)
  • S. Senthilkumar et al.

    Effect of squalene on cyclophosphamide-induced toxicity

    Clin. Chim. Acta

    (2006)
  • H.M. Shulman et al.

    An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation

    Gastroenterology

    (1980)
  • A. Srivastava et al.

    Hepatoprotective effect of the aqueous extract of the roots of Decalepis hamiltonii against ethanol-induced oxidative stress in rats

    Hepatol. Res.

    (2006)
  • A. Srivastava et al.

    Neuroprotective effect of Decalepis hamiltonii roots against ethanol-induced oxidative stress

    Food Chem.

    (2010)
  • A. Srivastava et al.

    Hepatoprotective effect of the root extract of Decalepis hamiltonii against carbon tetrachloride-induced oxidative stress in rats

    Food Chem.

    (2010)
  • A. Srivastava et al.

    Antioxidant activity of the roots of Decalepis hamiltonii (Wight and Arn.)

    LWT-Food. Sci. Technol.

    (2006)
  • A. Srivastava et al.

    Isolation of ellagic acid from the aqueous extract of the roots of Decalepis hamiltonii: antioxidant activity and cytoprotective effect

    Food Chem.

    (2007)
  • D.N. Tripathi et al.

    Astaxanthin intervention ameliorates cyclophosphamide-induced oxidative stress, DNA damage and early hepatocarcinogenesis in rat: role of Nrf2, p53, p38 and phase-II enzymes

    Mutat. Res.

    (2010)
  • M. Warholm et al.

    Glutathione transferase from human liver

    Methods Enzymol.

    (1985)
  • N.I. Weijl et al.

    Free radicals and antioxidants in chemotherapy-induced toxicity

    Cancer Treat. Rev.

    (1997)
  • Aebi, H., 1983. Methods of enzymatic analysis, Verlag Chenie, Weinheim, vol. 2, pp....
  • A. Aguilar-Mahecha et al.

    Chronic cyclophosphamide treatment alters the expression of stress response genes in rat male germ cells

    Biol. Reprod.

    (2002)
  • B. Anderstam et al.

    Lipid peroxide level in a murine adenocarcinoma exposed to hyperthermia: the role of glutathione depletion

    Radiat. Res.

    (1992)
  • A.M. Bacon et al.

    Cyclophosphamide hepatotoxicity in a patient with systemic lupus erythematosus

    Ann. Int. Med.

    (1982)
  • Calberg, I., Mannervik, B., 1985. Glutathione reductase. In: Meister, A. (Ed.). Method Enzymol., p. 113, pp....
  • Cited by (82)

    • Ameliorative effect of Lactobacillus plantarum Lp2 against cyclophosphamide-induced liver injury in mice

      2022, Food and Chemical Toxicology
      Citation Excerpt :

      Nevertheless, these strategies are limited in application because they are not as effective. Therefore, combining a treatment plan with potent and safe antioxidants may be the desirable approach to mitigate CTX-induced liver injury (Zarei and Shivanandappa, 2013). In recent years, some significant advances have been made in the probiotic functions of L. plantarum, such as antioxidant, anti-inflammatory and immunomodulatory effects (Choi et al., 2018; Jung et al., 2019; Zhao et al., 2019).

    View all citing articles on Scopus
    View full text